A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)

Clinical trial NCT05984784 · TERMINATED

Trial details

NCT number: NCT05984784
Sponsor: Inmagene LLC
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis Moderate-to-severe Atopic Dermatitis AD

Start date: 2023-08-09
Primary completion: 2024-04-26
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.